← Insider buys
KALV

KalVista Pharmaceuticals, Inc. · Healthcare

Novo Holdings A/s sold $1.3M of KalVista Pharmaceuticals, Inc.

10% owner

Sold$1,273,956
$7.21Price
176,644Shares
−6%Stake

What KALV did after the filing

Prices for KALV after this filing aren't in yet.

Traded Wed, Sep 13. Filed Mon, Sep 18, 7:04 PM ET, after the close. Not investment advice.